Akebia Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
Startup & Company Raises
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Akebia Therapeutics Inc
TickerAKBA
CIK #0001517022
CUSIP00972D105
SectorLife Sciences - Pharmaceutical Preparations
Address245 First Street Suite 1100, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2026
[0001517022] 10-K
[0001517022] 10-Q
[0001517022] 3
[0001517022] 4
[0001517022] 5
[0001517022] 8-K
[0001517022] SC 13D
[0001517022] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Akebia Therapeutics Inc [2025-04-30] 0.0
BlackRock Inc Akebia Therapeutics Inc [2024-11-08] 7.2
BlackRock Inc Akebia Therapeutics Inc [2024-10-22] 7.2
Satter Muneer A Akebia Therapeutics Inc [2022-12-19] 7.5
BlackRock Inc Akebia Therapeutics Inc [2022-07-08] 2.4
State Street Corp Akebia Therapeutics Inc [2021-02-11] 15.55
Vanguard Group Inc Akebia Therapeutics Inc [2021-02-10] 5.84
Wellington Management Group LLP Akebia Therapeutics Inc [2020-11-10] 12.35
Nantahala Capital Management LLC Akebia Therapeutics Inc [2020-02-13] 5.7
Baupost Group LLC/MA Akebia Therapeutics Inc [2019-01-09] 20.94
Abrams Capital Management LP Akebia Therapeutics Inc [2018-12-07] 0.0
Nantahala Capital Management LLC Akebia Therapeutics Inc [2018-09-26] 0.8
Novo Holdings A/S Akebia Therapeutics Inc [2018-02-13] 5.25
Satter Muneer A Akebia Therapeutics Inc [2017-07-14] 6.48
Vifor Pharma Ltd Akebia Therapeutics Inc [2017-05-22] 8.4
Nantahala Capital Management LLC Akebia Therapeutics Inc [2017-02-14] 5.8
FMR LLC Akebia Therapeutics Inc [2016-02-12] 0.0
BlackRock Inc Akebia Therapeutics Inc [2016-01-28] 5.5
Satter Muneer A Akebia Therapeutics Inc [2015-02-12] 7.8
Venture Investors Early Stage Fund IV LP Akebia Therapeutics Inc [2015-02-09] 5.7
Eagle Asset Management Inc Akebia Therapeutics Inc [2015-01-06] 6.01
Triathlon Medical Ventures Fund LP Akebia Therapeutics Inc [2014-04-29] 5.8
Novo A/S Akebia Therapeutics Inc [2014-04-03] 7.5
Novartis BioVentures Ltd Akebia Therapeutics Inc [2014-03-31] 16.81
Kearny Venture Partners LP Akebia Therapeutics Inc [2014-03-28] 5.6
Form 3/4/5 Filer 2011 - 2026
Akebia Therapeutics, Inc.
Ostrowski Erik
Zumwalt Leanne M
Malabre Richard C
Frieson Ron
Gilman Steven C
Rogers Michael W
Smith Cynthia
Wolf Myles
Adams Adrian
Burke Steven Keith
Butler John P.
Grund Nicholas
Dahan Michel
Hadas Nicole R.
Snow Ellen
Spellman David A
Cotreau Violetta
Faulkingham Dell
Heffernan Michael Thomas
Gowen Maxine
Enyedy Mark J
Tubridy Karen L
Amello Jason
Canute Scott A
Morrison Jodie Pope
Jain Rita
Wyzga Michael S
Satter Muneer A
Renaud Ronald C JR
Nash Duane
Clayman Michael D.
Maroni Bradley
Dalal Anupam
Shalwitz Robert
Novartis Bioventures Ltd
Novo Holdings A/S
Adox James R
Viesf IV GP LLC
Venture Investors LLC
Venture Investors Southeast LLC
Weiss Paul M
Peterson Loren G
Button Scott
Arida George
NEIS John
Venture Investors Early Stage Fund IV LP
Ganser Roger H
Nielsen Jack
Dueholm Kim
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 17,923,424 18,373,961
Vanguard Group Inc [2025-06-30] SOLE 0 14,354,498
State Street Corp [2025-06-30] DFND 7,655,291 7,997,153
Geode Capital Management LLC [2025-06-30] DFND 6,074,458 6,074,458
Morgan Stanley [2025-06-30] DFND 4,361,067 5,339,654
Renaissance Technologies LLC [2025-06-30] SOLE 4,194,427 4,194,427
Goldman Sachs Group Inc [2025-06-30] DFND 3,933,432 3,934,002
MPM BioImpact LLC [2025-06-30] SOLE 2,889,125 2,889,125
Nuveen, LLC [2025-06-30] DFND 2,700,981 2,708,676
Franklin Resources Inc [2025-06-30] DFND 2,665,386 2,667,412
Citadel Advisors LLC [2025-06-30] DFND 2,541,590 2,541,590
Millennium Management LLC [2025-06-30] SOLE 2,163,499 2,163,499
Northern Trust Corp [2025-06-30] DFND 2,095,638 2,095,638
Nantahala Capital Management LLC [2025-06-30] SOLE 2,000,000 2,000,000
Great Point Partners LLC [2025-06-30] SOLE 0 1,985,915
Affinity Asset Advisors LLC [2025-06-30] SOLE 1,950,000 1,950,000
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,714,544 1,714,544
JPMorgan Chase & Co [2025-06-30] DFND 1,417,321 1,652,746
Informed Momentum Co LLC [2025-06-30] SOLE 564,058 1,454,328
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 1,112,205 1,205,128
Connor Clark & Lunn Investment Management Ltd [2025-06-30] SOLE 1,180,759 1,180,759
Bank of America Corp /DE/ [2025-06-30] DFND 103,237 1,110,480
Woodline Partners LP [2025-06-30] SOLE 1,001,360 1,001,360
Susquehanna International Group LLP [2025-06-30] OTR 791,352 930,352
Dimensional Fund Advisors LP [2025-06-30] SOLE 685,341 861,816
FMR LLC [2025-06-30] DFND 805,846 813,982
Charles Schwab Investment Management Inc [2025-06-30] SOLE 749,015 749,015
Wellington Management Group LLP [2025-06-30] DFND 0 695,728
UBS Group AG [2025-06-30] DFND 596,962 639,462
Federated Hermes Inc [2025-06-30] DFND 617,318 617,318
Prev | Page 795 | Next
New Features
Service Providers Listing Leaderboards of the custodians, auditors, brokers, marketers, and fund sponsors behind private funds — ranked by assets and number of funds, each with its own page and a growth-over-time chart.
Latest Form D Offerings by VC, PE & Hedge Funds The newest private-fund Form D filings — venture capital, private equity, and hedge funds — with how much each is raising, its strategy, and the managers behind it. Filter by period and fund type.
Latest Form D Offerings by Companies Operating-company Regulation D raises (Databricks, Roboflow, and thousands more), ranked by amount raised and filterable by period and industry — the startup side of Form D, kept separate from pooled funds.
In the News Recent headlines gathered for the firms and funds people follow most, shown right on each firm and fund page — here it is live on a major manager's profile.
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com